Inozyme Pharma Ratios and Metrics

Market cap in millions NOK. Fiscal year is January - December.

Millions NOK. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul '25 Jul 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	1,466	1,363	1,395	855	520	-
Market Cap Growth	59.25%	-2.30%	63.20%	64.30%	-	-
Enterprise Value	1,918	1,589	1,474	656	455	-
Last Close Price	8.56	7.96	10.28	7.92	4.82	-
PE Ratio	-	-	1916.78	153.12	189.99	-
PS Ratio	-	-	23256.87	5662.28	273.60	-
PB Ratio	2.05	1.91	2.90	3.06	1.90	-
P/TBV Ratio	2.05	1.91	2.90	3.06	1.90	-
P/OCF Ratio	-	-	209.99	-	-	-
EV/Sales Ratio	-	-	24559.72	4347.60	239.13	-
Debt / Equity Ratio	0.65	0.63	0.27	-	-	-
Asset Turnover	-	-	0	0	0.01	-
Quick Ratio	0.53	1.63	2.97	5.17	16.00	940.01
Current Ratio	1.49	2.53	2.97	5.17	16.00	940.01
Return on Equity (ROE)	-0.46%	-0.35%	0.19%	2.02%	1.61%	-
Return on Assets (ROA)	-0.20%	-0.20%	-0.43%	-0.76%	-0.63%	-
Return on Capital (ROIC)	-0.21%	-0.21%	-0.47%	-0.84%	-0.66%	-
Earnings Yield	-0.19%	-0.15%	0.05%	0.65%	0.53%	-
FCF Yield	-32.95%	-37.07%	-28.46%	-8.96%	-1.46%	-
Buyback Yield / Dilution	-27.64%	-27.64%	-27.11%	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.